CAS 236395-14-5
:Acetic acid 5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10(S)-yl ester
Description:
Acetic acid 5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10(S)-yl ester, identified by its CAS number 236395-14-5, is a chemical compound that belongs to the class of dibenzoazepines, which are characterized by their fused aromatic and heterocyclic structures. This compound features a carbamoyl group, which contributes to its potential biological activity, and an ester functional group derived from acetic acid, indicating it may have applications in medicinal chemistry. The presence of the 10(S)-yl configuration suggests stereochemical specificity, which can influence its pharmacological properties. The compound's structure may allow for interactions with biological targets, making it of interest in drug development. Additionally, its solubility and reactivity can be influenced by the functional groups present, affecting its behavior in various chemical environments. Overall, this compound's unique structural features may provide insights into its potential uses in therapeutic applications, although specific biological activities would require further investigation through experimental studies.
Formula:C17H16N2O3
InChI:InChI=1/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1
InChI key:InChIKey=QIALRBLEEWJACW-INIZCTEOSA-N
SMILES:O(C(C)=O)[C@@H]1C=2C(N(C(N)=O)C=3C(C1)=CC=CC3)=CC=CC2
Synonyms:- (10S)-10-(Acetyloxy)-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
- (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
- (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
- (S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate
- 5H-Dibenz[b,f]azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)-
- Aptiom
- Bia 2-093
- Eslicarbazepine Acetate
- Exalief
- Exelief
- Sep 0002093
- Zebinix
- Licarbazepine Acetate S-Isomer
- Acetic acid 5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10(S)-yl ester
- S(+)-10-acetoxy-10,11-Dihydro-10-5H-dibenz[b,f]azepine-5-carboxamide
- Licarbazepine Impurity 4(Licarbazepine Acetate S-Isomer)
- Eslicarbazepine acetate (racemate)
- BIA 2-093;APTIOM
- Eslicarbazepine Acetate BIA 2-093
- EslicarbazepineAcetate>
- Acetic acid 5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl ester
- S-Licarbazepine Acetate
- Eslicarbazepine acetate Impurity
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
Eslicarbazepine Acetate
CAS:Formula:C17H16N2O3Purity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:296.33Eslicarbazepine Acetate
CAS:<p>Anticonvulsants, hypnotics and sedatives</p>Formula:C17H16N2O3Color and Shape:White Crystalline PowderMolecular weight:296.335H-Dibenz[b,f]azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)-
CAS:Formula:C17H16N2O3Purity:98%Color and Shape:SolidMolecular weight:296.3205(S)-Licarbazepine Acetate
CAS:Formula:C17H16N2O3Color and Shape:White To Off-White SolidMolecular weight:296.33Eslicarbazepine Acetate
CAS:<p>Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use as an adjunctive therapy for partial-onset seizures.</p>Formula:C17H16N2O3Purity:99.58% - >99.99%Color and Shape:White To Off-White SolidMolecular weight:296.32Eslicarbazepine Acetate
CAS:<p>Applications Eslicarbazepine acetate, (BIA 2-093), is a promising antiepileptic drug structurally related to Carbamazepine and Oxcarbazepine. Neuroprotective & Neuroresearch product.<br>References Benes, J., et al.: J. Med. Chem., 42, 2582 (1999), Tong, X., et al.: Br. J. Pharmacol., 133, 867 (2001), Almeida, L., et al.: J. Clin. Pharmacol., 45, 1062 (2005), Elger, C., et al.: Epilepsia, 48, 497 (2007),<br></p>Formula:C17H16N2O3Color and Shape:White To Light BrownMolecular weight:296.32Eslicarbazepine acetate
CAS:<p>Eslicarbazepine acetate is an anticonvulsant drug that has been shown to be effective in reducing the frequency of seizures. It is a prodrug and is metabolized by esterases to form the active form, eslicarbazepin acetate. Eslicarbazepine acetate inhibits glutamate release by acting on the glutamate transporter, which prevents depolarization of the mitochondrial membrane potential, leading to inhibition of epileptic activity. Eslicarbazepine acetate also decreases brain levels of GABA and increases levels of polyamines such as spermidine and spermine, which are neuroprotective. There are some reports of hepatic impairment when eslicarbazepine acetate is used with other drugs that are metabolized through this organ (e.g., valproic acid).<br>Eslicarbazepine acetate can cause chemical stability issues when exposed to light or air due to oxidation reactions. It may also react</p>Formula:C17H16N2O3Purity:Min. 95%Color and Shape:PowderMolecular weight:296.32 g/mol(S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate
CAS:Formula:C17H16N2O3Purity:98%+;RGMolecular weight:296.326Eslicarbazepine Acetate-D3
CAS:Controlled Product<p>Applications Eslicarbazepine acetate-D3 is a labelled analogue of Eslicarbazepine acetate (E659000), a voltage-gated sodium channel blocker and antiepileptic that is used to treat patients with epilepsy.<br>References Almeida, L., et al.: Eur. J. Clin. Pharmacol., 64, 267 (2008); Gil-Nagel, A., et al.: Acta Neurol. Scand., 120, 281 (2009); McCormack, P. & Robinson, D.: CNS Drugs, 23, 71 (2009)<br></p>Formula:C17H13D3N2O3Color and Shape:NeatMolecular weight:299.34











